Dengue endgame summit
On behalf of the Global Health Institute at SUNY Upstate Medical University we are delighted to welcome you to the YouTube page of the Dengue Endgame Summit.
Recent advances in dengue vaccines, antivirals, therapeutics, biologics, and vector control have renewed hope that dengue control may be an achievable goal. However, these technological and medical advances are emerging into a world challenged by climate change, increasing urbanization, expanded regional and international travel, and viral evolution. Our collective optimism is currently being tempered by the harsh reality of dengue on the ground, where we are witnessing record breaking dengue outbreaks around the world and increasing morbidity and mortality. However, we strongly believe there is reason for hope and an opportunity for the scientific, medical, and public health communities to unite and advance towards a future where dengue and other vector-borne diseases are concerns of the past.
Daniel Munblit, MD, PhD. 2025 Dengue Endgame Summit
Julio Croda, MD, PhD. 2025 Dengue Endgame Summit.
Andre Siqueira, MD. 2025 Dengue Endgame Summit
In Kyu Yoon, MD. 2025 Dengue Endgame Summit
Jenny Low Guek Hong, MD. 2025 Dengue Endgame Summit
Kirsten Lyke, MD. 2025 Dengue Endgame Summit
Ashley Lauren St John, PhD. 2025 Dengue Endgame Summit
Bridget Wills, FRCPCH, DM. 2025 Dengue Endgame Summit
Morgan A Marks, PhD. 2025 Dengue Endgame Summit
Eng Eong Ooi, MD, PhD. 2025 Dengue Endgame Summit
Chantal Vogels, PhD. 2025 Dengue Endgame Summit
Jason Rasgon, PhD. 2025 Dengue Endgame Summit
Albert Ko, MD. 2025 Dengue Endgame Summit
Shirin Kalimuddin, MBBS, MPH, PhD. 2025 Dengue Endgame Summit
Angkana T Huang, PhD. 2025 Dengue Endgame Sunmmit
Jing Shen, PhD. 2025 Dengue Endgame Summit
Henrik Salje, PhD. 2025 Dengue Endgame Summit
Kathryn Anderson, MD PhD. 2025 Dengue Endgame Summit
Tahmina Shirin, PhD. 2025 Dengue Endgame Summit
John Waitumbi, DVM, PhD. 2025 Dengue Endgame Summit
Jana Shaw, From Doubt to Trust: Strategies to Combat Vaccine Hesitancy in the United States
Priscila Da Silva Castanham, Discovery of Biomarkers via Epitope Surrogate Technology
Hoe Nam Leong, Dengue Vaccines - Asian Perspectives
Ilaria Dorigatti, Challenges and opportunities in modeling dengue interventions
Alex Perkins: Sustainable control of DENV will require coordinated deployment of multiple approaches
Lillian Chiang: Human SIRT2, an intrinsic immunity target for medical countermeasure development
Rebecca Christofferson: "Vectors and vector control: historical challenges and modern solutions"
Scott Halstead: "Dengue: confronting the pandemic"
Stephen Thomas: "Lessons Learned from the Dengue Human Infection Model Consortium"
Kirk Prutzman: "Regulatory considerations for models for dengue vaccine evaluation"